830 related articles for article (PubMed ID: 25327790)
21. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
[TBL] [Abstract][Full Text] [Related]
22. Do breast columnar cell lesions with atypia need to be excised?
Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K
Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063
[TBL] [Abstract][Full Text] [Related]
23. Morphometric Analysis in the Diagnosis of Low-Grade Ductal and Lobular Carcinoma in Situ of the Breast.
Parra-Herran C; Hope T; Rashed T; Slodkowska E; Lu FI; Nofech-Mozes S
Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):331-8. PubMed ID: 26860008
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R; Zhuang Z; Merino MJ; Silverberg SG
Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
[TBL] [Abstract][Full Text] [Related]
25. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
26. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
27. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
[TBL] [Abstract][Full Text] [Related]
28. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
[TBL] [Abstract][Full Text] [Related]
30. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
Kwaepila N; Burns G; Leong AS
Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
[TBL] [Abstract][Full Text] [Related]
31. Incidental finding of mammary carcinoma in lumpectomy specimens.
Tang P; Hajdu SI; Conte CC; Filardi DA
Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
[TBL] [Abstract][Full Text] [Related]
32. Fine-needle aspiration cytology of lobular carcinoma in situ.
Ustün M; Berner A; Davidson B; Risberg B
Diagn Cytopathol; 2002 Jul; 27(1):22-6. PubMed ID: 12112810
[TBL] [Abstract][Full Text] [Related]
33. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
34. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
35. Mixed apocrine/endocrine ductal carcinoma in situ of the breast coexistent with lobular carcinoma in situ.
Coyne JD; Dervan PA; Barr L; Baildam AD
J Clin Pathol; 2001 Jan; 54(1):70-3. PubMed ID: 11271793
[TBL] [Abstract][Full Text] [Related]
36. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
37. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
38. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies.
Gao F; Carter G; Tseng G; Chivukula M
Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524
[TBL] [Abstract][Full Text] [Related]
39. [The value of immunohistochemical expression of Ki-67 and CD34 in differentiating ductal carcinoma in situ from ductal carcinoma in situ-like invasive breast cancer].
Pan XY; Wu JK; Lang ZQ; Qu L; Jiang L
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):838-842. PubMed ID: 36097899
[No Abstract] [Full Text] [Related]
40. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
